Paragraph 16 I1
United Kingdom
After Schedule 2 insert—
“SCHEDULE 3
Maximum residue level supplementary information fees F1chargeable by a Great Britain competent authority
Regulation 4(2A)
Fees chargeable by a Great Britain competent authority for the evaluation of supplementary information provided in accordance with Article 14(3) of the MRL Regulation are in accordance with the following table.
Item Category Fee (£) 1 Preliminary consideration of application to determine whether the application can proceed further 229 2 Co-ordination of applications 1,872 3 Simple reasoned case(1) 416 4 Analytical method(2) 416 5 Toxicology(3) 3,120 6 Metabolism and residues evaluation(4) 6,760 7 Residues evaluation(5) 2,028 Notes
(1)This category is for an MRL supplementary information requirement to provide additional information on aspects of the data already evaluated or to provide evidence of the commercial availability of standards for MRL compliance.
(2)This category is for an MRL supplementary information requirement to provide an analytical method for MRL compliance.
(3)This category is for an MRL supplementary information requirement to address the toxicological relevance of a metabolite identified in plants or products of animal origin.
(4)This category is for an MRL supplementary information requirement to address plant or livestock metabolism or any other nature of residue study.
(5)This category is for an MRL supplementary information requirement to provide additional residue trials or any other magnitude of residue study including monitoring data.
Fees for multiple submissions to address MRL supplementary information for the same active substance are calculated on a modular basis with a charge applied for each MRL supplementary information requirement. Large or novel studies to address MRL supplementary information requirements will incur an additional fee, as a multiple of the original fee, if significant extra work is required over and above the usual level for the module in question.”
Annotations
Textual amendments
- F1
Words in Sch. 1 para. 16 inserted (31.12.2020 immediately before IP completion day) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 1 para. 12
Commencement
- I1
Sch. 1 para. 16 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)